Weiss Multi-Strategy Advisers’s QIAGEN NV QGENF Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-50,000	Closed	-$1.05M	–	1137
2014 Q1	$1.05M	Buy	+50,000	New	+$1.05M	0.02%	467
2013 Q4	–	Sell	-60,000	Closed	-$1.28M	–	1266
2013 Q3	$1.28M	Buy	+60,000	New	+$1.28M	0.03%	383

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Weiss Multi-Strategy Advisers's QGENF Position: Q3 2016 in Review

Weiss Multi-Strategy Advisers sold out of QIAGEN NV (QGENF) in Q3 2016, closing a stake of 10,935 shares — an estimated $238K sold.

Weiss Multi-Strategy Advisers first reported a position in QGENF in Q3 2013 and held it in 10 quarters. The position peaked at $734K in Q2 2014. 210 funds tracked by Wall St. Rank hold QGENF as of Q3 2016.

Weiss Multi-Strategy Advisers reported no remaining QIAGEN NV position as of Q3 2016 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 10,935 QIAGEN NV shares in Q3 2016, an estimated $238K.
Weiss Multi-Strategy Advisers first reported a position in QIAGEN NV in Q3 2013 and held it in 10 quarters.
Weiss Multi-Strategy Advisers's QIAGEN NV position peaked at $734K in Q2 2014.
210 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.